Introduction
Bladder cancer, cancer, Cancer
RECURRENCE, BLADDER CANCER, CANCER, CANCER
Bladder cancer (BC) is the tenth most common cancer worldwide with a significant morbidity burden associated with high recurrence and progression rates [European Organisation for Research and Treatment of Cancer (EORTC) and Club Urologico Español de Tratamiento Oncologico (CUETO) scoring models are well-established tools for the estimation of recurrence- and progression-free survival in NMIBC [Artificial intelligence becomes an attractive option, with deep learning as a promising tool for pattern recognition and outcome prediction [In this population-based study, we aimed to identify factors associated with OS and CSS in patients with T1 NMIBC treated with TURBT. Furthermore, we aimed to compare the utility of ANN and conventional machine learning tools – LR in the prediction of 5-year CSS and OS in patients with T1 NMIBC.